OncoPep Garners $6,900,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    520 Boston Street North Andover, MA 01845 USA
  • Company Description
    OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds raised will support the clinical development of PVX-410, currently being studied in patients with smoldering multiple myeloma (SMM), an asymptomatic stage of MM.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy